by PVA_Admin | Mar 15, 2022 | 2022 Press Release, Press Release
JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), announced today that their recent...
by PVA_Admin | Mar 8, 2022 | Cold Plasma Publications, Publications
BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer Saravana R. K. Murthy, Xiaoqian Cheng, Taisen Zhuang, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar, & Jerome Canady Breast cancer is the most common cause...
by PVA_Admin | Oct 6, 2021 | 2021 Press Release, Press Release
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological...
by PVA_Admin | Sep 12, 2021 | Cold Plasma Publications, Publications
Canady Helios Cold Plasma Induces Breast Cancer Cell Death by Oxidation of Histone mRNA by Xiaoqian Cheng, Saravana R. K. Murthy, Taisen Zhuang,Lawan Ly,Olivia Jones, Giacomo Basadonna, Michael Keidar, Yasmine Kanaan and Jerome Canady Breast cancer is the most common...
by PVA_Admin | Sep 9, 2021 | 2021 Press Release, Press Release
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a U.S....
